Co-founder of the Center for Assessment Technology and Continuous Health (CATCH), a MGH/MIT-based digital health initiative
Dr. Shaywitz is a graduate of Harvard College (summa cum laude), and received his MD from the Health Sciences and Technology program at Harvard Medical School and MIT, and his PhD from the Department of Biology at MIT. He trained in internal medicine and endocrinology at MGH, and conducted his post-doctoral research in the Melton lab at Harvard. He gained experience in early clinical drug development in the Department of Experimental Medicine at Merck, then joined the Boston Consulting Group’s Healthcare and Corporate Development practices, where he focused on strategy and organizational design. He is currently Director of Strategic and Commercial Planning at Theravance, a publicly-held drug development company in South San Francisco.
Dr. Shaywitz is a co-founder (with Dennis Ausiello) of the Harvard PASTEUR program, a translational research initiative at Harvard Medical School. He is also a founding advisor of Sage, a non-profit medical research initiative (founded by Eric Schadt and Stephen Friend) emphasizing networks and open innovation (www.sagebase.org). More recently, he co-founded the Center for Assessment Technology and Continuous Health (CATCH), a MGH/MIT-based digital health initiative led by Dennis Ausiello, and focused on using improved real-world phenotypic assessment to improve care and advance science.
For the last fifteen years, Dr. Shaywitz has contributed commentaries about medicine, science, strategy, innovation and digital health to a number of popular publications, including The New York Times, The Washington Post, The Wall Street Journal, Politico Pro, and The Financial Times. He currently is a regular contributor to Forbes.com andTheAtlantic.com.
Dr. Shaywitz is an Adjunct Scholar at the American Enterprise Institute. His email is: davidshaywitz.aei@gmail.com .
